Shane Raines

2.0k total citations
38 papers, 1.4k citations indexed

About

Shane Raines is a scholar working on Psychiatry and Mental health, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Shane Raines has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Molecular Biology and 7 papers in Cognitive Neuroscience. Recurrent topics in Shane Raines's work include Schizophrenia research and treatment (7 papers), Bipolar Disorder and Treatment (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Shane Raines is often cited by papers focused on Schizophrenia research and treatment (7 papers), Bipolar Disorder and Treatment (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Shane Raines collaborates with scholars based in United States, Sweden and Australia. Shane Raines's co-authors include James Doherty, Stephen Kanes, Ethan Hoffmann, Helen Colquhoun, Samantha Meltzer‐Brody, David R. Rubinow, Wayne Macfadden, Robert M. A. Hirschfeld, Eduard Vieta and Kristina M. Deligiannidis and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Shane Raines

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shane Raines United States	20	458	259	252	228	209	38	1.4k
Nan-Tsing Chiu Taiwan	22	333 0.7×	116 0.4×	334 1.3×	49 0.2×	160 0.8×	82	1.6k
Qing Lü China	26	397 0.9×	229 0.9×	85 0.3×	49 0.2×	260 1.2×	200	2.8k
Jan Versijpt Belgium	28	991 2.2×	153 0.6×	347 1.4×	72 0.3×	263 1.3×	78	2.5k
Wei Yao Taiwan	20	171 0.4×	115 0.4×	231 0.9×	36 0.2×	181 0.9×	72	1.2k
H. M. Schulte Germany	24	121 0.3×	115 0.4×	273 1.1×	102 0.4×	214 1.0×	55	2.1k
Carl Johan Ekman Sweden	27	866 1.9×	154 0.6×	92 0.4×	32 0.1×	291 1.4×	49	1.9k
Robert M. Schwarcz United States	24	163 0.4×	36 0.1×	450 1.8×	139 0.6×	282 1.3×	50	1.9k
P. Sirota Israel	23	527 1.2×	89 0.3×	228 0.9×	28 0.1×	476 2.3×	67	1.7k
Ömer Kitiş Türkiye	20	237 0.5×	75 0.3×	190 0.8×	54 0.2×	74 0.4×	93	1.6k
Annemarie Wijkhuijs Netherlands	19	274 0.6×	70 0.3×	34 0.1×	195 0.9×	153 0.7×	30	1.2k

Countries citing papers authored by Shane Raines

Since Specialization

Citations

This map shows the geographic impact of Shane Raines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Raines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Raines more than expected).

Fields of papers citing papers by Shane Raines

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Raines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Raines. The network helps show where Shane Raines may publish in the future.

Co-authorship network of co-authors of Shane Raines

This figure shows the co-authorship network connecting the top 25 collaborators of Shane Raines. A scholar is included among the top collaborators of Shane Raines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane Raines. Shane Raines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panizza, Benedict, Stephen O’Leary, Christopher D. Hart, et al.. (2025). Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity. Journal of Clinical Oncology. 43(19). 2155–2163.

Marek, Gerard J., Daniel Umbricht, Edward P. Christian, et al.. (2025). A novel psychedelic 5-HT _2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer. Journal of Psychopharmacology. 4126427472–4126427472. 1 indexed citations

Shaffer, Rebecca C., Angela John Thurman, Lucienne Ronco, et al.. (2022). Social communication in fragile X syndrome: pilot examination of the Brief Observation of Social Communication Change (BOSCC). Journal of Neurodevelopmental Disorders. 14(1). 4–4.

Deligiannidis, Kristina M., et al.. (2022). Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder with peripartum onset: A multicenter, open-label, controlled proof-of-concept clinical trial (DELOS-1). Journal of Affective Disorders. 316. 34–41. 12 indexed citations

Perlin, David S., Garry A. Neil, Colleen Anderson, et al.. (2021). Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome. Journal of Clinical Investigation. 132(3). 21 indexed citations

Hoffmann, Ethan, George G. Nomikos, Inder Kaul, et al.. (2019). SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies. Clinical Pharmacokinetics. 59(1). 111–120. 45 indexed citations

Rosenthal, Eric S., Jan Claassen, Mark S. Wainwright, et al.. (2017). Brexanolone as adjunctive therapy in super‐refractory status epilepticus. Annals of Neurology. 82(3). 342–352. 78 indexed citations

Kanes, Stephen, Helen Colquhoun, Handan Gunduz‐Bruce, et al.. (2017). Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. The Lancet. 390(10093). 480–489. 304 indexed citations

Kanes, Stephen, George G. Nomikos, Michael C. Quirk, et al.. (2017). 75. A Single-Ascending Dose Study of the Neuroactive Steroid SAGE-217. Biological Psychiatry. 81(10). S31–S31. 1 indexed citations

10.

Litman, Robert E., Mark A. Smith, James Doherty, et al.. (2016). AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study. Schizophrenia Research. 172(1-3). 152–157. 66 indexed citations

11.

Ellenbogen, Aaron, Shane Raines, & Stephen Kanes. (2016). Exploratory Trial Results for SAGE-547 in Essential Tremor (P4.297). Neurology. 86(16_supplement). 3 indexed citations

12.

Wang, Gang, et al.. (2014). A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder. Neuropsychiatric Disease and Treatment. 10. 201–201. 18 indexed citations

13.

Raines, Shane, et al.. (2014). Ropivacaine for Continuous Wound Infusion for Postoperative Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. European Surgical Research. 53(1-4). 43–60. 35 indexed citations

14.

Angiolillo, Dominick J., Catherine Datto, Shane Raines, & Neville D. Yeomans. (2013). Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies. Journal of Thrombosis and Thrombolysis. 38(1). 11–23. 16 indexed citations

15.

Stedman, Mary, Helen M. Pettinati, E. Sherwood Brown, et al.. (2010). A Double‐Blind, Placebo‐Controlled Study With Quetiapine as Adjunct Therapy With Lithium or Divalproex in Bipolar I Patients With Coexisting Alcohol Dependence. Alcoholism Clinical and Experimental Research. 34(10). 1822–1831. 52 indexed citations

16.

Banov, Michael, David E. Adson, Catherine Datto, et al.. (2010). Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆. Journal of Affective Disorders. 128(1-2). 83–94. 62 indexed citations

17.

Vieta, Eduard, et al.. (2007). Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid‐cycling disease course: a randomized, double‐blind, placebo‐controlled study. Bipolar Disorders. 9(4). 413–425. 78 indexed citations

18.

Chapple, Christopher R., Albena Patroneva, & Shane Raines. (2006). Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004). European Urology. 49(5). 879–886. 37 indexed citations

19.

Hirschfeld, Robert M. A., et al.. (2006). Quetiapine in the Treatment of Anxiety in Patients With Bipolar I or II Depression. The Journal of Clinical Psychiatry. 67(3). 355–362. 69 indexed citations

20.

Norman, J. Farley & Shane Raines. (2002). The perception and discrimination of local 3-D surface structure from deforming and disparate boundary contours. Perception & Psychophysics. 64(7). 1145–1159. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact